These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17964990)

  • 1. [Target antigens for therapeutic antibodies in oncology: many candidates, few successes].
    Ceze N; Probst A; Lecomte T; Ohresser M; Paintaud G; Watier H
    Bull Cancer; 2007; 94(7 Suppl):F129-36. PubMed ID: 17964990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
    Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY
    Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
    Weiner LM; Clark JI; Ring DB; Alpaugh RK
    J Hematother; 1995 Oct; 4(5):453-6. PubMed ID: 8581384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.
    Noguchi T; Kato T; Wang L; Maeda Y; Ikeda H; Sato E; Knuth A; Gnjatic S; Ritter G; Sakaguchi S; Old LJ; Shiku H; Nishikawa H
    Cancer Res; 2012 Apr; 72(7):1672-82. PubMed ID: 22318866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of 27 Tumor-Associated Antigens by Histochemical Analysis of 36 Freshly Resected Lung Cancer Tissues.
    Kurosawa G; Sugiura M; Hattori Y; Tsuda H; Kurosawa Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic antibodies to intracellular targets in cancer therapy.
    Veomett N; Dao T; Scheinberg DA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1485-8. PubMed ID: 23991764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
    Korver W; Singh S; Liu S; Zhao X; Yonkovich S; Sweeney A; Anton K; Lomas WE; Greenwood R; Smith A; Tran DH; Shinkawa P; Jimenez M; Yeung P; Aguilar G; Palencia S; Vatta P; Mueller M; Zhan X; Newton EM; Liu Y; Zhao J; Emtage P; Levy MD; Hsi ED; Funk WD; Abo A
    Br J Haematol; 2007 May; 137(4):307-18. PubMed ID: 17456053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of therapeutic antibodies for cancer.
    Redman JM; Hill EM; AlDeghaither D; Weiner LM
    Mol Immunol; 2015 Oct; 67(2 Pt A):28-45. PubMed ID: 25911943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms.
    Cleary KLS; Chan HTC; James S; Glennie MJ; Cragg MS
    J Immunol; 2017 May; 198(10):3999-4011. PubMed ID: 28404636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody mechanisms of action in cancer.
    Weiner GJ
    Immunol Res; 2007; 39(1-3):271-8. PubMed ID: 17917071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies: better knowledge for a better use].
    Abès R; Dutertre CA; Teillaud JL
    Med Sci (Paris); 2009 Dec; 25(12):1011-9. PubMed ID: 20035672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
    Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
    Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.
    Yip YL; Ward RL
    Cancer Immunol Immunother; 2002 Jan; 50(11):569-87. PubMed ID: 11807621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody].
    Shimodaira H; Komine K; Soeda H; Ishioka C
    Gan To Kagaku Ryoho; 2010 May; 37(5):795-8. PubMed ID: 20495309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of cell surface antigens for antibody targeting in oncology.
    Carter P; Smith L; Ryan M
    Endocr Relat Cancer; 2004 Dec; 11(4):659-87. PubMed ID: 15613445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro.
    Robinson MK; Hodge KM; Horak E; Sundberg AL; Russeva M; Shaller CC; von Mehren M; Shchaveleva I; Simmons HH; Marks JD; Adams GP
    Br J Cancer; 2008 Nov; 99(9):1415-25. PubMed ID: 18841159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.
    Gan HK; Burgess AW; Clayton AH; Scott AM
    Cancer Res; 2012 Jun; 72(12):2924-30. PubMed ID: 22659454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.